Tech Company Financing Transactions

Exicure Funding Round

Cascade Investment, private investors and Rathmann Family Foundation participated in a $13.6 million Series C capital raise for Exicure. This venture round was announced on 6/17/2014.

Transaction Overview

Company Name
Exicure
Announced On
6/17/2014
Transaction Type
Venture Equity
Amount
$13,600,000
Round
Series C
Investors

Cascade Investment (William Gates)

private investors (Boon Koh)

private investors (Craig Mundie)

private investors (David Walt)

private investors (Patrick Ryan)

Rathmann Family Foundation

Proceeds Purpose
"Based on the success AuraSense Therapeutics has had in its extensive animal trials, we have ambitious plans to rapidly advance SNA constructs into the clinic," said Dr. David Giljohann, Chief Executive Officer of AuraSense Therapeutics.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8045 Lamon Ave. 410
Skokie, IL 60077
USA
Phone
(847) 673-1700
Website
www.exicuretx.com
Email Address
Not Recorded
Overview
AuraSense Therapeutics is a development-stage biotechnology company founded to pursue the unique commercial potential of Spherical Nucleic Acid (SNA) constructs. These novel constructs possess unparalleled biocompatibility and versatility as therapeutics.
Profile
Exicure LinkedIn Company Profile
Social Media
Exicure Company Twitter Account
Company News
Exicure News
Facebook
Exicure on Facebook
YouTube
Exicure on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Giljohann
  David Giljohann LinkedIn Profile  David Giljohann Twitter Account  David Giljohann News  David Giljohann on Facebook
Chief Financial Officer
David Snyder
  David Snyder LinkedIn Profile  David Snyder Twitter Account  David Snyder News  David Snyder on Facebook
Chief Operating Officer
Matthias Schroff
  Matthias Schroff LinkedIn Profile  Matthias Schroff Twitter Account  Matthias Schroff News  Matthias Schroff on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/17/2014: Virtru venture capital transaction
Next: 6/17/2014: Lucid venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.